Matches in Wikidata for { <http://www.wikidata.org/entity/Q98498040> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q98498040 description "article scientifique publié en 2020" @default.
- Q98498040 description "artículu científicu espublizáu n'agostu de 2020" @default.
- Q98498040 description "scientific article published on 13 August 2020" @default.
- Q98498040 description "wetenschappelijk artikel" @default.
- Q98498040 description "наукова стаття, опублікована 13 серпня 2020" @default.
- Q98498040 name "Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway" @default.
- Q98498040 name "Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway" @default.
- Q98498040 type Item @default.
- Q98498040 label "Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway" @default.
- Q98498040 label "Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway" @default.
- Q98498040 prefLabel "Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway" @default.
- Q98498040 prefLabel "Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway" @default.
- Q98498040 P1433 Q98498040-BBECC9BD-E61F-43D1-8527-F718AD90AF15 @default.
- Q98498040 P1476 Q98498040-9A2B91DE-1460-4F7C-ACC5-70665EA54195 @default.
- Q98498040 P2093 Q98498040-3310640A-A0A0-4B55-B6EB-A3FA55837151 @default.
- Q98498040 P2093 Q98498040-421E7685-AACB-4311-94B4-A15061E5013B @default.
- Q98498040 P2093 Q98498040-6769A660-A8E6-43EC-9FB8-1389E647976E @default.
- Q98498040 P2093 Q98498040-6E483238-0FF6-4949-9DF5-E4F29A59703F @default.
- Q98498040 P2093 Q98498040-9144815A-2932-4A69-A0A8-A9148717DE55 @default.
- Q98498040 P2093 Q98498040-F0730585-250E-4B04-9933-25EFDD0C123E @default.
- Q98498040 P31 Q98498040-92D7ABA9-2A4A-41A4-B4C8-962B65D83E85 @default.
- Q98498040 P356 Q98498040-70B7FD56-5FCC-48EC-ABB4-52E528A85A64 @default.
- Q98498040 P577 Q98498040-8441BA22-7401-47B8-A0FA-FAE85C677D71 @default.
- Q98498040 P698 Q98498040-A516D45E-38B8-49CD-954B-88E221AAF5C8 @default.
- Q98498040 P356 J.BBRC.2020.07.049 @default.
- Q98498040 P698 32800546 @default.
- Q98498040 P1433 Q864228 @default.
- Q98498040 P1476 "Combination of lapatinib and luteolin enhances the therapeutic efficacy of lapatinib on human breast cancer through the FOXO3a/NQO1 pathway" @default.
- Q98498040 P2093 "Aixue Liu" @default.
- Q98498040 P2093 "Fan Yang" @default.
- Q98498040 P2093 "Jiren Zhang" @default.
- Q98498040 P2093 "Li Huang" @default.
- Q98498040 P2093 "Lingyan Zhang" @default.
- Q98498040 P2093 "Qingjun Liu" @default.
- Q98498040 P31 Q13442814 @default.
- Q98498040 P356 "10.1016/J.BBRC.2020.07.049" @default.
- Q98498040 P577 "2020-08-13T00:00:00Z" @default.
- Q98498040 P698 "32800546" @default.